Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001104659-21-085707
Filing Date
2021-06-25
Accepted
2021-06-25 16:07:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM 8-A12B tm2120699d1_8a12b.htm 8-A12B 15210
  Complete submission text file 0001104659-21-085707.txt   16194
Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-A12B | Act: 34 | File No.: 001-40544 | Film No.: 211047744
SIC: 2834 Pharmaceutical Preparations